| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/25/2009 | CN100471522C Polynucleotide compsn. method of prepn. and use thereof |
| 03/24/2009 | US7507811 siRNA targeting KRAS |
| 03/24/2009 | US7507810 Compositions and their uses directed to IL-4R alpha |
| 03/24/2009 | US7507808 Modulation of endothelial lipase expression |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507802 inducing immune activation of T-helper 1 type; anti-cancer treatments; bacteria is Escherichia coli or mycobacteria; synergistic mixture |
| 03/24/2009 | US7507801 therapies and screening methods for a variety of disorders including but not limited to: myeloid malignancies such as acute myelogenous leukemia, myelodysplastic syndrome, polycythemia vera and juvenile chronic myelogenous leukemia; autoimmune diso |
| 03/24/2009 | US7507798 Antibody specific for mutant presenilin 1 |
| 03/24/2009 | US7507714 For stimulating insulin release from pancreatic beta cells in glucose-dependent fashion; treatment of metabolic disorders such as those resulting from decreased endogenous insulin secretion, in particular type 2 diabetics, or for patients with impaired glucose tolerance |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507530 Nanoparticle complexes having a defined number of ligands |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507416 adjuvant compound chosen from the acrylic or methacrylic polymers and the copolymers of maleic anhydride and an alkenyl derivative especially with polyalkenyl ethers of sugars or polyalcohols; heterologus influenza protein |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2407894C Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 03/24/2009 | CA2320717C Method for the treatment of diseases or disorders of the inner ear |
| 03/21/2009 | CA2603615A1 Methods of reducing viral infection and kits therefore |
| 03/19/2009 | WO2009035804A2 Gene silencing of the brother of the regulator of imprinted sites (boris) |
| 03/19/2009 | WO2009035216A1 Cell delivery system for cell therapy comprising cells derived from embryonic stem cells |
| 03/19/2009 | WO2009035160A1 Candidate molecule for falciparum malaria vaccine |
| 03/19/2009 | WO2009034127A1 Use of the cyp46a1 gene for the treatment of alzheimer's disease |
| 03/19/2009 | WO2009033411A1 Method and composition for cancer diagnosis and treatment |
| 03/19/2009 | WO2009012363A3 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
| 03/19/2009 | WO2009002790A3 Compositions and methods for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| 03/19/2009 | WO2008157419A3 Immunogenic peptides of influenza virus |
| 03/19/2009 | WO2008109142A3 Pirna and uses related thereto |
| 03/19/2009 | WO2007047609A3 INHIBITION OF PLACENTA GROWTH FACTOR (PlGF) MEDICATED METASTASIS AND/OR ANGIOGENESIS |
| 03/19/2009 | WO2005086684A3 Method for modulating, regulating and/or stabilizing angiogenesis |
| 03/19/2009 | WO2005069987A3 Amplifying interfering rna (rnai) expression and effects |
| 03/19/2009 | US20090077681 Methods for Diagnosing and Treating Heart Disease |
| 03/19/2009 | US20090076246 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 03/19/2009 | US20090075889 Iren protein, its preparation and use |
| 03/19/2009 | US20090075873 Gastrin compositions and formulations, and methods of use and preparation |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075379 Modulation of homologous recombination with single stranded dna binding proteins |
| 03/19/2009 | US20090075376 METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA |
| 03/19/2009 | US20090075373 Neural progenitor cells derived from embryonic stem cells |
| 03/19/2009 | US20090075369 Angiostatin Fragments and Method of Use |
| 03/19/2009 | US20090075334 screening for a compound to change binding of ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; drug screening; used in treating HIV infection, cancer, and various other diseases and disorders |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074849 Cancer-suppressing agents |
| 03/19/2009 | US20090074794 for use in the treatment of crohn's and ulcerative colitis; administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8 |
| 03/19/2009 | US20090074784 Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells |
| 03/19/2009 | US20090074726 Mva expressing modified hiv envelope, gag, and pol genes |
| 03/19/2009 | US20090074724 Materials and methods for inhibiting wip1 |
| 03/19/2009 | US20090074723 Method of Treating or Retarding the Development of Blindness |
| 03/19/2009 | US20090074722 Products and methods for treating PTP lar diseases |
| 03/19/2009 | US20090074665 Diagnosis and treatment of cancer:I |
| 03/19/2009 | DE102007044093A1 Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Induktion antimikrobieller Peptide in epithelialen Deckgeweben Nucleic acid-containing cosmetic and / or pharmaceutical preparations for the induction of antimicrobial peptides in epithelial tissues deck |
| 03/19/2009 | CA2698400A1 Method and composition for cancer diagnosis and treatment |
| 03/18/2009 | EP2036985A1 Antibody gene transfer and recombinant AAV therefor |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells |
| 03/18/2009 | EP2034955A2 Collagen scaffolds, medical implants with same and methods of use |
| 03/18/2009 | EP2034954A2 Non-viral compositions and methods for transfecting gut cells in vivo |
| 03/18/2009 | EP1945773B1 Recombinant expression of multiprotein complexes using polygenes |
| 03/18/2009 | EP1907015A4 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 03/18/2009 | EP1565579B1 Methods for identifying risk of breast cancer |
| 03/18/2009 | EP1218489B1 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/18/2009 | EP1030929B1 Transfection and transfer of non-human male germ cells for generation of transgenic non-human mammals |
| 03/18/2009 | EP0741783B1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 03/18/2009 | CN101389761A De-differentiation of astrocytes into neural stem cell using bmi-1 |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101389345A Combinatorial methods and compositions for treatment of melanoma. |
| 03/18/2009 | CN101386869A Human methyl guanine methyl transferase gene eucaryon expression plasmid and construction method and application thereof |
| 03/18/2009 | CN101386848A MiRNA with cell corpuscule as vector and preparation research approach thereof and application |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101385850A Treatment of cellular proliferative disorders |
| 03/18/2009 | CN100469887C Carotene synthase gene and uses therefor |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/17/2009 | US7504385 si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
| 03/17/2009 | US7504257 Embryonic stem cells and neural progenitor cells derived therefrom |
| 03/17/2009 | US7504223 Using variation in annexin 7 (ANX7) gene expression as diagnostic tool in detection of mammary gland cell proliferative disorders |
| 03/17/2009 | US7504212 Cancer monitoring and therapeutics |
| 03/17/2009 | US7504206 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/17/2009 | US7504108 Polypeptides; immunogenic compositions; generating immune responses; kits |
| 03/17/2009 | US7504100 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 03/17/2009 | US7504099 Regeneration of tendons by grafting genetic engineered stem cells comprises nucleic acid coding for BMP-2 and SMAD proteins or variants |
| 03/17/2009 | US7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore |
| 03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/17/2009 | CA2258882C Compositions and methods for altering the biodistribution of biological agents |
| 03/17/2009 | CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/12/2009 | WO2009033162A1 Gene targets in anti-aging therapy and tissue repair |
| 03/12/2009 | WO2009033091A1 Treatment of th17-mediated autoimmune disease via inhibition of stat3 |
| 03/12/2009 | WO2009032364A1 Activation of nuclear factor-kappa b |
| 03/12/2009 | WO2009032194A1 Wnt pathway stimulation in reprogramming somatic cells |
| 03/12/2009 | WO2009031911A1 Cationic liposome carrier for genetic drugs |
| 03/12/2009 | WO2009031671A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 03/12/2009 | WO2009031635A1 Recombinant vector for treatment of nephrogenic diabetes insipidus, and use thereof |
| 03/12/2009 | WO2009030789A1 Method for the diagnosis and/or prognosis of breast cancer |
| 03/12/2009 | WO2009030650A1 Inflammation-induced anti-inflammatory gene expression |
| 03/12/2009 | WO2009030481A1 Complexes of rna and cationic peptides for transfection and for immunostimulation |
| 03/12/2009 | WO2009030254A1 Complexes of rna and cationic peptides for transfection and for immunostimulation |
| 03/12/2009 | WO2009030153A1 The roles of mirnas in the diagnosis and treatment of systemic lupus erythematosus |
| 03/12/2009 | WO2009030084A1 NEW FUNCTIONS AND USES OF HUMAN ONCOGENE-LIKE SMALL G PROTEIN RabJ |
| 03/12/2009 | WO2009030025A1 Porcine adeno-associated viruses |